Intrauterine Contraceptive Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
- January 2034
- Healthcare IT
- 0 pages
Intrauterine contraceptive device (IUD) is a T-shaped, small-sized, birth control device that is inserted into woman’s uterus to prevent pregnancy. These devices are highly effective, economical, and safe birth control devices. IUDs are considered 99% safe in preventing pregnancy. The contraceptive effect of IUDs is attributable to the localized inflammation that occurs after insertion. The inflammatory reaction in the uterus produces substances that are poisonous for sperms. This affects fertilization. Intrauterine devices can be used immediately after delivery, as they do not affect breastfeeding. These can also be used after abortion. IUDs provide several advantages. They prevent pregnancy for a long time; reduce the chances of ectopic pregnancy; and do not cause discomfort during sex. Once an IUD is removed, the user can quickly return to fertility.
Two types of intrauterine devices available in the U.S. are copper-releasing IUDs and progesterone-releasing IUDs. Copper-releasing IUDs function by releasing copper that is wrapped around the base. The released copper initiates inflammatory reaction in the uterus, which prevents fertilization of the egg. Copper-releasing IUDs are approved for use up to 10 years. Progesterone-releasing IUDs release progestin, which acts by thickening the cervical mucus and creating a barrier to sperms. It also renders the uterus lining unreceptive to implantation of the egg.
The intrauterine contraceptive devices market is expected to witness high growth during the forecast period, due to the rising number of initiatives to promote the use of these devices and growing rate of unintended pregnancies. However, a few disadvantages associated with the use of IUDs such as prolonged and heavy bleeding, irregular bleeding, cramps, and pain during monthly bleeding are likely to hamper the market during the forecast period. Moreover, low adoption of intrauterine contraception in developing countries led by rumors and myths about the method, insufficient emphasis during contraceptive consultations, and insufficient provider experience may hinder the market from 2017 to 2025.
The global intrauterine contraceptive devices market can be segmented on the basis of product, end–user, and region. Based on product, the market has been classified into medicated IUDs and non-medicated IUDs. Based on end-user, the market can be divided into hospitals, gynecology clinics, and community health care centers. Based on region, the global intrauterine contraceptive devices market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
In terms of revenue, Asia Pacific is expected to account for the maximum share of the global market during the forecast period. High government initiatives for population control in countries such as India and China, growing awareness about IUDs among adolescents and adults, and growing baby boomer population in Asia Pacific are some of the factors augmenting the market in the region. Europe is expected to hold the second-largest share of the global market between 2017 and 2025. Factors contributing to high market share held by Europe are increasing prevalence of sexually transmitted diseases (STDs) and high awareness about contraceptives among women in the region. Other regions such as Middle East & Africa and Latin America are expected to offer growth opportunities to the intrauterine contraceptive devices market in the near future. These regions are expected to be potential markets in the near future due to high adoption of IUDs and technologically advanced instruments and growth of the health care industry in the region.
The global intrauterine contraceptive devices market is highly fragmented due to presence of several existing as well as new players in the market. Major players operating in the market are DKT International, Melbea AG, Pregna International Limited, Ocon Medical Ltd, SMB Corporation of India, and Mona Lisa N.V..
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare IT
Healthcare ITGlobal mHealth Market Research Report 2016
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017